Immunocore Holdings (IMCR) EPS (Basic) (2021 - 2026)
Immunocore Holdings (IMCR) posted quarterly EPS (Basic) of $0.26 for Q1 2026, up 156.83% year-on-year from $0.1 in Q1 2025, and up 142.8% on a QoQ basis from -$0.6 in Q4 2025.
Immunocore Holdings (IMCR) EPS (Basic) (2021 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported EPS (Basic) for 6 consecutive years, with $0.26 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) rose 156.83% year-over-year to $0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.54 (down 25.56% YoY) and the FY2025 annual result came in at -$0.71, up 30.97% from the prior year.
- EPS (Basic) rose to $0.26 in Q1 2026 per IMCR's latest filing, from -$0.6 in the prior quarter.
- Over the last five years, EPS (Basic) for IMCR reached as high as $0.26 in Q1 2026 and fell as low as -$0.65 in Q4 2022.
- A 5-year average of -$0.22 and a median of -$0.3 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 847.12% — and 2025, when it slumped 102.23%.
- Year by year, EPS (Basic) stood at -$0.65 in 2022, then soared by 38.24% to -$0.4 in 2023, then fell by 17.83% to -$0.48 in 2024, then declined by 25.57% to -$0.6 in 2025, then jumped by 142.8% to $0.26 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.26, -$0.6, and -$0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | 0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | -0.60 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.20 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | -0.48 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | -0.23 |
| Mar 31, 2024 | -0.49 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.40 |
| Dec 31, 2022 | -0.65 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | -0.45 |
| Dec 31, 2021 | -1.25 |
| Sep 30, 2021 | -0.95 |